Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.
Pretreatment multi‐biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial
The Multi‐Biomarker Disease Activity Test for Rheumatoid Arthritis: Is It a Valid Measure of Disease Activity?
Predictive ability, validity, and responsiveness of the multi-biomarker disease activity score in patients with rheumatoid arthritis initiating methotrexate.
https://pubmed.ncbi.nlm.nih.gov/32911284/